These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections? Benecke R, Heinze A, Reichel G, Hefter H, Göbel H, Dysport myofascial pain study group. Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970 [Abstract] [Full Text] [Related]
30. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study. Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT. Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577 [Abstract] [Full Text] [Related]
31. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ. Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830 [Abstract] [Full Text] [Related]
33. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches. Relja M, Poole AC, Schoenen J, Pascual J, Lei X, Thompson C, European BoNTA Headache Study Group. Cephalalgia; 2007 Jun; 27(6):492-503. PubMed ID: 17428299 [Abstract] [Full Text] [Related]
34. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Gazerani P, Pedersen NS, Staahl C, Drewes AM, Arendt-Nielsen L. Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549 [Abstract] [Full Text] [Related]
35. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients. Ma K, Jiang W, Zhou Q, Du DP. Int J Clin Pract; 2008 Feb; 62(2):241-7. PubMed ID: 18070045 [Abstract] [Full Text] [Related]
37. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial. Sahai A, Dowson C, Khan MS, Dasgupta P. BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019 [Abstract] [Full Text] [Related]
38. Neuro-reflexotherapy for the management of myofascial temporomandibular joint pain: a double-blind, placebo-controlled, randomized clinical trial. Berguer A, Kovacs F, Abraira V, Mufraggi N, Royuela A, Muriel A, Gestoso M, Falahat F, Martín-Granizo R, Zamora J. J Oral Maxillofac Surg; 2008 Aug; 66(8):1664-77. PubMed ID: 18634956 [Abstract] [Full Text] [Related]